A combination of vinorelbine and oxaliplatin to restrain the progression of non-small cell lung cancer via inhibition of the PI3K/AKT/ABCG2 axis
A combination of vinorelbine and oxaliplatin to restrain the progression of non-small cell lung cancer via inhibition of the PI3K/AKT/ABCG2 axis. Pharmacognosy Magazine [Internet]. 2022;18(80):859-870. http://www.phcog.com/text.asp?2022/18/80/859/361762
.